Grand Rapids, MI, United States of America

Mark E Gurney

USPTO Granted Patents = 59 


 

Average Co-Inventor Count = 4.4

ph-index = 14

Forward Citations = 366(Granted Patents)


Inventors with similar research interests:


Location History:

  • E. Grand Rapids, MI (US) (2009)
  • Reykjavik, IS (2004 - 2010)
  • East Grand Rapids, MI (US) (2010)
  • Grand Rapids, MI (US) (2002 - 2023)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
59 patents (USPTO):

Title: The Innovative Contributions of Mark E. Gurney in Pharmaceutical Research

Introduction: Mark E. Gurney, based in Grand Rapids, MI, is a notable inventor with an impressive portfolio of 58 patents. His work primarily focuses on pharmaceuticals, specifically targeting the treatment of inflammatory diseases through innovative compounds. Gurney's contributions reflect a dedication to advancing medical science and improving patient outcomes.

Latest Patents: Among his significant inventions, Gurney's latest patents feature "Heteroaryl inhibitors of PDE4". This invention pertains to compounds and methods that act as inhibitors of phosphodiesterase 4 (PDE4), which are crucial for the treatment or prevention of inflammatory diseases and conditions involving elevated levels of cytokines and pro-inflammatory mediators. The repeated mention of this particular patent underscores its importance in his research portfolio.

Career Highlights: Gurney has made substantial contributions to the pharmaceutical industry through his work at reputable companies. He has been associated with Pharmacia & Upjohn Company and Decode Genetics Ehf, where he collaborated with teams to drive innovative research and development projects. His extensive experience has equipped him with a deep understanding of drug development processes and patient needs.

Collaborations: Throughout his career, Gurney has worked alongside distinguished colleagues, including Michael Jerome Bienkowski and Robert L. Heinrikson. These collaborations have played a significant role in fostering innovation and driving forward groundbreaking research initiatives in the field of pharmaceuticals.

Conclusion: Mark E. Gurney's impressive array of patents and his work in pharmaceutical research reflect a commitment to improving healthcare outcomes through innovation. His contributions, particularly in the realm of anti-inflammatory therapies, demonstrate the impact that dedicated inventors can have on medical science and patient care. Gurney continues to inspire future generations of inventors and researchers in the quest for solutions to complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…